N-[5-fluoro-3-[hydroxy(methoxy)methoxy]-5-(hydroxymethyl)-3-methyloxolan-2-yl]-N-methylacetamide
C11H20FNO6 — CID 123381059
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-fluoro-3-[hydroxy(methoxy)methoxy]-5-(hydroxymethyl)-3-methyloxolan-2-yl]-N-methylacetamide
N-[5-fluoro-3-[hydroxy(methoxy)methoxy]-5-(hydroxymethyl)-3-methyloxolan-2-yl]-N-methylacetamide (PubChem CID 123381059) has the molecular formula C11H20FNO6 and a molecular weight of 281.28 g/mol. Its IUPAC name is N-[5-fluoro-3-[hydroxy(methoxy)methoxy]-5-(hydroxymethyl)-3-methyloxolan-2-yl]-N-methylacetamide.
Molecular Properties
| Compound Name | N-[5-fluoro-3-[hydroxy(methoxy)methoxy]-5-(hydroxymethyl)-3-methyloxolan-2-yl]-N-methylacetamide |
|---|---|
| PubChem CID | 123381059 |
| Molecular Formula | C11H20FNO6 |
| Molecular Weight | 281.28 g/mol |
| Exact Mass | 281.13 |
| IUPAC Name | N-[5-fluoro-3-[hydroxy(methoxy)methoxy]-5-(hydroxymethyl)-3-methyloxolan-2-yl]-N-methylacetamide |
| SMILES | COC(O)OC1(C)CC(F)(CO)OC1N(C)C(C)=O |
| InChI | InChI=1S/C11H20FNO6/c1-7(15)13(3)8-10(2,19-9(16)17-4)5-11(12,6-14)18-8/h8-9,14,16H,5-6H2,1-4H3 |
| InChIKey | KRSLBJWRFRTCBG-UHFFFAOYSA-N |
| XLogP | -0.43 |
| TPSA | 88.46 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 19 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 281.28 |
| LogP ≤ 5 | -0.43 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123381059 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.